Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer

Junko Akaishi1, Masamitsu Onda, Junichi Okamoto

  • 1Department of Molecular Biology, Institute of Gerontology, Nippon Medical School, Kanagawa, Japan. s4067@nms.ac.jp <s4067@nms.ac.jp>

BMC Cancer
|November 2, 2006
PubMed
Abstract

Insights

Down-regulation of transcription elongation factor A (SII)-like 4 (TCEAL4) was observed in anaplastic thyroid cancer (ATC). Loss of TCEAL4 expression may contribute to ATC development from differentiated thyroid cancer (DTC).

Area of Science:

  • Molecular oncology
  • Cancer genetics
  • Thyroid cancer research

Background:

  • Anaplastic thyroid cancer (ATC) is a highly aggressive malignancy, often developing from differentiated thyroid cancer (DTC).
  • The molecular mechanisms driving the transformation from DTC to ATC are not fully understood.
  • Transcription elongation factor A (SII)-like 4 (TCEAL4) is a gene family member with largely undescribed functions and no previously reported association with human cancers.

Purpose of the Study:

  • To investigate the potential role of TCEAL4 in the carcinogenesis of anaplastic thyroid cancer.
  • To analyze TCEAL4 expression patterns in various thyroid cancer subtypes and normal tissues.

Main Methods:

  • Gene expression profiling using cDNA microarray analysis was previously employed to identify candidate genes in ATC.
  • TCEAL4 expression levels were examined in anaplastic thyroid cancer (ACLs), other thyroid cancer types, and normal human thyroid tissues.

Main Results:

  • TCEAL4 expression was significantly down-regulated in all 11 analyzed ACL samples compared to normal thyroid tissues.
  • Reduced TCEAL4 expression was also observed when compared to papillary and follicular thyroid cancerous tissues.
  • TCEAL4 demonstrated ubiquitous expression across all tested normal human tissues, indicating its widespread normal function.

Conclusions:

  • This study reports for the first time altered TCEAL4 expression in human cancers.
  • The observed down-regulation suggests a potential association between TCEAL4 loss and the development of ATC from DTC.
  • Further functional studies are necessary to elucidate the precise role of TCEAL4 in thyroid cancer progression.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Transcription Elongation Factors02:35

Transcription Elongation Factors

Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA into a...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...